FDA's 2026 rules draw a clearer line between HSAT devices and consumer wearables. Here is what family physicians need to understand about pulse oximeter readings, OSA diagnosis, and where clinical responsibility begins.

As seasons change, COPD exacerbation risks increase. Learn how integrating a pulse oximeter with BiPAP machine therapy enables proactive COPD management and reduces hospital readmissions.

Discover how wearable devices in HSAT are revolutionizing the detection of sleep apnea and heart failure, paving the way for large-scale screening and enhanced patient compliance.

etects moderate-to-severe OSA, correlating well with PSG measures. Its low cost and ease of use make it a practical tool for at-home screening and ongoing OSA diagnosis and management.